크레오에스지

040350KOSDAQ컴퓨터 프로그래밍, 시스템 통합 및 관리업

57.0 / 100

Reference Date: 2026-06-10

Financial Score6.0 / 40

News Sentiment20.0 / 25

Momentum19.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Surged 1197.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Creo SG operates in three main business segments: financial IT solutions, biotech vaccine development, and real estate operations. The solution segment provides core banking systems to banks and non-banks, while the biotech segment focuses on developing vaccines for AIDS, COVID-19, and superbugs, though it currently generates no revenue. The real estate segment manages properties through a subsidiary.

Number of Employees

48people

Average Salary

57.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.114.0Point

PBR

3.93Industry Average 0.870.0Point

4.5x industry avg (risky)

ROE

-17.52Industry Average 6.290.0Point

Well below industry avg

Debt Ratio

69.35Industry Average 10.070.0Point

6.9x industry avg (risky)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼32.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -30.1% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 80

Positive
크레오에스지, 질병청 마버그열 백신 개발 과제 참여…차세대 팬데믹...
크레오스지가 차세대 마버그열 백신 개발에 참여함으로써 감염병 대응 능력 강화에 기여할 것으로 기대된다.
Positive
지엔코, 35억원 규모 3자배정 유상증자 납입 완료 …
크레오스지의 자금 조달 성공으로 인한 재무 구조 개선 기대감 증가.

Detailed Momentum

52-week position8.0Point

Near 52w high (100%, uptrend)

Current 9,500Won52-week high 9,50052-week low 556

1-month return6.0Point

1m +1197.81% (strong rise)

Volume trend5.0Point

Volume flat

Detailed Disclosure

6 totalPositive 1Neutral 5Negative 0

Neutral조회공시요구(현저한시황변동)에대한답변(미확정)2026-06-09
Neutral조회공시요구(현저한시황변동)2026-06-08
Neutral대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Positive단일판매ㆍ공급계약체결2026-05-22
Neutral증권발행결과(자율공시) (제24회차 CB)2026-05-18